glycyl-arginyl-glycyl-aspartyl-seryl-proline and Hepatocellular Carcinoma

glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Imlau, U; Oppermann, E; Qian, J; Qian, K; Tran, A; Vogl, TJ	1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Hepatocellular Carcinoma

Article	Year
Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World journal of gastroenterology, 2016, Jun-07, Volume: 22, Issue:21 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Chemoembolization, Therapeutic; Ethiodized Oil; Hepatic Artery; Immunohistochemistry; Injections, Intra-Arterial; Integrins; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 9; Nanomedicine; Nanoparticles; Oligopeptides; Rats, Inbred ACI; Tumor Burden; Vascular Endothelial Growth Factor A	2016

Article

Year

Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.

World journal of gastroenterology, 2016, Jun-07, Volume: 22, Issue:21

Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Chemoembolization, Therapeutic; Ethiodized Oil; Hepatic Artery; Immunohistochemistry; Injections, Intra-Arterial; Integrins; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 9; Nanomedicine; Nanoparticles; Oligopeptides; Rats, Inbred ACI; Tumor Burden; Vascular Endothelial Growth Factor A

2016